IBD & Intestinal Disorders
News from the FDA/CDC
FDA approves upadacitinib for Crohn’s disease
The approval is noteworthy because it marks the first oral small molecule treatment for CD.
Conference Coverage
Meat heavy diets may lead to ulcerative colitis flares
Patients with ulcerative colitis and meat-heavy diets had twice as many flares as those who ate less meat.
Conference Coverage
At-home monitoring device can predict Crohn’s disease flares
A new device developed at Massachusetts Institute of Technology shows promise.
Conference Coverage
Fewer discontinuations with infliximab vs. vedolizumab for UC maintenance therapy
Findings are based on a pooled analysis of six randomized controlled trials from the past 10 years.
From the AGA Journals
Psyllium may shield against colitis
A mouse study suggests an effect on inflammation by boosting bile acid metabolism.
Sponsored Supplement
Three Clinical Studies Demonstrating Safety and Efficacy of Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) in Adults
From the Journals
Gut microbiome may guide personalized heart failure therapy
Understanding the gut microbiome and how it may affect development and treatment of heart failure could lead to a more personalized approach to...
Latest News
FMT in a pill: FDA approves second product to prevent C. diff recurrence
Clinicians now have two approved options for recurrent infections after antibiotic treatment.
From the Journals
Pediatric Crohn’s disease: Adalimumab plus methotrexate offers strong benefit
“We believe these results are practice-changing.”
Latest News
Patients with IBD express need for psychosocial support
AGA launches My IBD Life campaign to support patients with IBD and encourage providers to play a role.
From the AGA Journals
Clinical Practice Update: Alpha-gal syndrome often causes GI issues without anaphylaxis, skin changes
“It is important for gastroenterologists to be aware of this condition and to be capable of diagnosing and treating it in a timely manner.”